Safety of rituximab therapy during twins' pregnancy

Authors:

Abstract
Sir, RA affects women more than men and often during childbearing years. Treatment during pregnancy is necessary to control maternal disease in favour of successful pregnancy outcome [1]. Rituximab, a chimeric immunoglobulin G1 (IgG1) monoclonal anti-CD20 antibody depletes circulating B cells and decreases RA activity [2].

This publication has 12 references indexed in Scilit: